Previous close | 12.89 |
Open | 12.89 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 17.50 |
Expiry date | 2025-12-19 |
Day's range | 12.89 - 12.89 |
Contract range | N/A |
Volume | |
Open interest | 41 |
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.